Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.
Forgot Your Password?
Follow Topic
Bookmark
Copy Link
Nemolizumab (Nemluvio, Galderma) has been approved by the MHRA for the treatment of two skins conditions.
18 Feb 2025 , 1 Min Article
This CPD module provides an overview of some of the major developments in pharmacy practice during 2018.
14 Dec 2018 , 900 Min Module
This CPD module provides an overview of key practice developments of 2017.
13 Dec 2017 , 900 Min Module
